Whitepaper & Video Center

With many in the industry now bouncing back from the challenges of the COVID-19 pandemic, we are seeing an increasing number of brands overhauling their marketing strategies to best succeed in this reformed landscape. In this case study, we examine how Sanofi is transforming its branding and marketing to move forwards from the crisis.

Click the image on the left to download now!Oncology breakthroughs are currently fueling significant growth in the market, as well as the competition between pharmaceutical brands for market share. This paper examines the challenges facing pharmaceutical brands today, as well as the strategies for non-personal promotion and boosting the informative value of their messaging that will allow them to continue to break through the competition. Key topics include: How constricted access to Oncologists is characterizing the marketCauses and symptoms of market changeAdapting to restrictions in Oncologist accessCrafting promotional strategies incorporating non-personal promotionPerceptions of multichannel effectiveness

In this research report, based on findings of an exclusive elandas webinar hosted by PharmaForce, you'll discover the three fundamental challenges of influencing decision makers, and how to use a combination of technology and strategy to overcome them.  Click the image to the left to download! 

With the importance of each decision maker engagement increased as a result of consolidated buying power in the healthcare market, getting the right shareable assets to support new opportunities is a critical part of a successful sales and marketing dynamic. In this report, produced with elandas, you'll discover three surprising integrations that can support a stronger approach to engagement while minimizing turnaround time. Read the latest on: -Overcoming information gaps to better enable sales -The impact of integrated healthcare networks on strategy -Producing custom assets to support new opportunities Click to download your copy!

Two-thirds of all product launches underperform and the majority of launches fail due to lack of preparation. We’ll discuss how your brand can achieve launch excellence through the three pillars for success: people, process, and expertise. This report will also examine the value of engaging an external launch partner and how they can offer can offer both strategic consultation and execution resources.

In this exclusive presentation from PharmaForce, Liz Cermak, Chief Commercial Officer for Pozen, discusses the future of pharma marketing and non-personal promotion. Cermak examines how Pozen is dealing with seismic changes in the sales rep model and explains how they've adapted to the changing attitudes of prescribers by implementing 21st century sales procedures. Click on the image at left to download the presentation; share around the office or use it as the basis of your next meeting.

Timely business insights hold the key to successfully competing in an increasingly digital world. Life sciences companies have invested millions in legacy business intelligence (BI) tools to deliver those insights to their commercial teams; however, they have failed to maximize ROI from those solutions characterized by limited scalability and low user adoption. Artificial intelligence (AI)-powered BI platforms provide life sciences companies with game-changing capabilities. These next-generation tools deliver cognitive insights based on billions of records in a matter of seconds – by simply asking a question in natural language. An AI-powered cognitive insights platform can finally enable life sciences companies to provide easy access to the information – their commercial teams need the most – when they need it. Complete this brief form to download our white paper ‘Achieving the Vision of What BI Should Be: The Path to Real-Time Insights for Life Sciences Commercial Teams’ to learn: Barriers that prevent life sciences organizations from easily accessing data-driven insights The advantages of a next-generation cognitive insights platform over legacy BI tools The impact pre-trained AI for life sciences can have on performance and total cost of ownership (TCO) New functionality that AI offers, including proactive insights and automatic alerts based on user behaviors Cognitive insights platforms increase productivity by 5x, increase user adoption to 100%, reduce dependency on IT by 40% and reduce the TCO by 50%. When it comes to data analytics and actionable insights, a cognitive insights platform will make life sciences companies unstoppable.

The fundamentals of pharma marketing have changed. Brands can no longer differentiate themselves through innovative product development alone. Instead, they must also differentiate themselves by understanding the needs of patients and their physicians, and by marketing based on context. This report explores how pharmaceutical companies are shifting their product marketing strategies from product-focused to audience-focused.